Terns Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Terns Pharmaceuticals has filed a definitive proxy statement with the SEC regarding its upcoming shareholder meeting.
NASDAQ
Terns Pharmaceuticals will hold its 2025 Annual Meeting of Stockholders online on June 11, 2025, to elect directors and ratify the appointment of its independent accounting firm.
NASDAQ
Terns Pharmaceuticals, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Terns Pharmaceuticals will hold its 2024 Annual Meeting of Stockholders online on June 10, 2024, to elect directors and ratify the selection of its independent accounting firm.